Patents
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
06/2006
06/01/2006US20060116374 substituted bis/thiohydrazide amide compound; synergistic effect with taxol or taxotere, anticancer agents, side effect reduction
06/01/2006US20060116329 Halothenoyl-cyclopropane-1-carboxylic acid derivatives
06/01/2006US20060114552 Fluorinated crosslinked electro-optic materials and electro-optic devices therefrom
06/01/2006DE102004056820A1 Preparation of dihydroindene derivatives comprises reacting benzene compounds with indene compounds in the presence of catalyst system containing e.g. ligand and a solvent system containing two solvents from e.g. tertiary amine and alcohol
06/01/2006CA2588607A1 Carbazole, carboline and indole derivatives useful in the inhibition of vegf production
06/01/2006CA2588599A1 2,3,4-substituted-cyclopentanones as therapeutic agents
06/01/2006CA2587134A1 Azine compounds for combating animal pests
05/2006
05/31/2006EP1660474A1 Substituted thiophenes and uses thereof
05/31/2006EP1660472A1 Aryl piperidine amides
05/31/2006EP1660471A1 Derivatives of hydroxamic acid as metalloproteinase inhibitors
05/31/2006EP1660440A2 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
05/31/2006EP1660436A1 Cathepsin inhibitors
05/31/2006EP1660427A1 Substituted arylalkanoic acid derivative and use thereof
05/31/2006EP1660096A1 Cyclohexyl prostaglandin analogs as ep-4 -receptor agonists
05/31/2006EP1659863A2 Pesticidally active phenol derivatives
05/31/2006EP1501820B1 Methylthiophene carboxanilides
05/31/2006EP1420644B1 Substituted propargylamines
05/31/2006EP1368336B1 Thiophene substituted amine derivatives as glyt-1 inhibitors
05/31/2006EP1296931B1 Polyamine analogues as cytotoxic agents
05/31/2006EP1251822A4 Novel coupler for use in oxidative hair dyeing
05/31/2006EP0946501B1 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
05/31/2006CN1780829A Fluoro- and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof
05/31/2006CN1780823A Heteroaromatic pentacyclic compound and medicinal use thereof
05/31/2006CN1778803A Production of d-biotin
05/31/2006CN1257900C Alkylation of thiophene compounds and their use in desulfuration of fractional oil
05/31/2006CN1257886C Dehydroamino acids compounds
05/30/2006US7053234 Antibacterial agents
05/30/2006US7053228 Cushing disease; antidepressant; modulate immunology response
05/30/2006US7053212 Subtype selectivity; cyclohexanecarboxylic acid (4-hydroxy-benzyl)-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-amide for example; treating estrogen-related disorders such as sexual disorders, bone disorders; reduction of tamoxifen uterotropic effect
05/30/2006US7053109 Aminediols for the treatment of Alzheimer's disease
05/30/2006US7053104 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
05/30/2006US7053094 Increasing contractile force in cardiac muscle fiber by administering a N-[(3-yloxy)-phenyl]-arylamide derivatives; modulating at the cardiac sarcomere (cardiac beta myosin) for congestive heart failure
05/30/2006US7052885 Process for preparing heterocyclic (R)- and (S)-cyanohydrins
05/30/2006US7052742 Five membered-ring compounds and utilization thereof in liquid crystal mixtures
05/26/2006WO2006055725A2 Substituted amino acids as protein tyrosine phosphatase inhibitors
05/26/2006WO2006055481A1 2,3,4-substituted cyclopentanones as therapeutic agents
05/26/2006WO2006055187A1 Sulfonyl-substituted bicyclic compounds as modulators of ppar
05/26/2006WO2006054426A1 Hydrophobic fluorescent probe of high-fluorescent quantum efficiency type, and method of detecting biopolymer and method of detecting interaction between biopolymers by using the same
05/26/2006WO2006053791A2 Compounds that modulate ppary type receptors, and use thereof in cosmetic or pharmaceutical compositions
05/26/2006WO2006053757A1 Process for preparing low molecular weight olefin polymers, organometallic transition metal compounds biscyclopentadienyl ligand systems and catalyst systems
05/26/2006WO2006053748A1 Substituted [(phenylethanoyl)amino] benzamides and the use thereof in the treatment of inflammatory and cardio-vascular diseases
05/26/2006CA2588776A1 Substituted amino carboxylic acids
05/26/2006CA2588475A1 Subnanomolar precipitator of thiophilic metals
05/26/2006CA2588056A1 2,3,4-substituted cyclopentanones as therapeutic agents
05/26/2006CA2587545A1 Novel compounds that modulate ppar.gamma. type receptors, and use thereof in cosmetic or pharmaceutical compositions
05/26/2006CA2587511A1 Substituted [(phenylethanoyl)amino] benzamides and the use thereof in the treatment of inflammatory and cardio-vascular diseases
05/26/2006CA2585172A1 Sulfonyl-substituted bicyclic compounds as modulators of ppar
05/25/2006US20060111431 Thiophene carboxanmides as inhibitors of the enzyme ikk-2
05/25/2006US20060111430 2,3,4-substituted cyclopentanones as therapeutic agents
05/25/2006US20060111406 Amide linker peroxisome proliferator activated receptor modulators
05/25/2006US20060111304 For therapy of pancreatitus, bilioecholic, gastroesophical relux (GERD), irritable bowel syndrome (IBS), non ulcerous dyspepsia
05/25/2006US20060108564 1,4-Bis-( alpha -cyano-4-methoxystyryl)-benzene, 1,4-bis-( alpha -cyano-4-methoxystyryl)-2,5-dimethoxybenzene, and 1,4-bis-( alpha -cyano-4-(2-ethylhexyloxystyryl)-2,5-dimethoxybenzene and 2,5-bis-( alpha -cyano-4-methoxystyryl)-thiophene; emission spectrum is dependent on supramolecular architecture
05/24/2006EP1659120A1 3-substituted quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists
05/24/2006EP1658263A1 Novel aminobenzophenone compounds
05/24/2006DE102004056104A1 Preparation of olefin polymers comprises (co)polymerization of an olefin in the presence of hydrogen and a catalyst system containing organo-transition metal component and a co-catalyst system
05/24/2006CN1777577A Antibacterial agents
05/24/2006CN1257153C Novel propargylether derivatives
05/23/2006US7049629 Semiconductor polymers and devices thereof
05/23/2006US7049445 for treating or preventing diabetes, obesity, hyperlipidemia, digestive diseases, depression or urinary disturbances; beta 3-agonist
05/23/2006US7049378 Polymerization of olefin
05/23/2006US7049337 Treating schizophrenia, Parkinson's disease, and cocaine addiction; Central Nervous System (CNS); ring systems substituted with an alkynylamino group; for example, 2-(N-propyn-3-yl-N-(2-cyanoethyl)amino)naphth-7-ol
05/23/2006US7049306 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4.
05/23/2006CA2158454C Taxanes having furyl or thienyl substituted side-chain
05/18/2006WO2006052722A1 Glycogen phosphorylase inhibitor compounds and pharmaceutical compositions thereof
05/18/2006WO2006051397A2 Oligonucleotide probes
05/18/2006WO2006051137A1 Method of obtaining derivatives of 4-(n-alkylamine)-5,6-dihydro-4h-thieno-[2,3-b]-thiopyran
05/18/2006US20060106256 e.g. 1-[(benzylamino)methyl]-3-(3,5-difluorophenyl)-2-({3-[(dipropylamino)carbonyl]benzoyl}amino)propyl 4-nitrophenyl carbonate; secretase inhibitors; neurodegenerative disorders; Alzheimer's, Parkinson's diseases, Down syndrom, Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-Type
05/18/2006US20060106247 Catalytic hydrogenation of carbon-heteroatom double bonds
05/18/2006US20060106088 Compounds for inflammatory bowel disease treatment with prodrug
05/18/2006US20060106072 Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors
05/18/2006US20060106067 Androgen receptor agonist; prostate cancer, hypogonadism; 4-[4-(hydroxymethyl)-1-piperidinyl]-1-naphthonitrile; 4-(4-hydroxy-2-methyl-1-pyrrolidinyl-1-benzothiophene-7-carbonitrile
05/18/2006US20060106053 Therapy of adenocarcinoma of the colon and rectum
05/18/2006US20060106030 N-(4-(4-(2,3 -dichlorophenyl)piperazin-1-yl)but-2-enyl)-1H-indole-2-carboxamide; imaging agents; tomography;diagnosis/medical/; selective, oral bioavailable drugs; nervous system disorders; central nervous system;oral administration; substance abuse ( cocaine/amphetamine); psychosis; Parkinson's
05/18/2006US20060106017 Novel o-acyloxime derivatives, preparation method thereof, and pharmaceutical composition containing the same for prevention and treatment of cardiovascular disease
05/18/2006CA2586446A1 Glycogen phosphorylase inhibitor compounds and pharmaceutical compositions thereof
05/17/2006EP1657954A1 Transmitter of wireless microphone, receiver for wireless microphone, mobile information communication apparatus, and communication system for wireless microphone
05/17/2006EP1656348A1 Acetylene derivatives as inhibitors of histone deacetylase
05/17/2006EP1481012B1 Open-chain alkoxyamines and their corresponding nitroxides for controlled low temperature radical polymerization
05/17/2006EP1109787B1 Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp)
05/17/2006CN1774433A Substituted 3-cyanothiophene acetamides as glucagon receptor antagonists
05/17/2006CN1772749A Fungicides for the control of take-all disease of plants
05/17/2006CN1772748A Antifungal compound and its prepn process and application
05/17/2006CN1256324C Pyrrolidine derivatives as factor Xa inhibitors
05/16/2006US7045558 Method of making a high refractive index optical management coating and the coating
05/16/2006US7045551 such as (R)-N-[2-hydroxy-1-(3-morpholin-4-yl-phenyl)-ethyl]-3-phenyl-propionamide; for treatment of migraines, bipolar disorders, epilepsy, acute/chronic pain and anxiety
05/16/2006US7045541 Compounds for the treatment of metabolic disorders
05/16/2006US7045540 Selective estrogen receptor modulators
05/16/2006US7045532 ACE-2 modulating compounds and methods of use thereof
05/16/2006CA2197628C Substituted thiophenylalkenylcarboxylic acid guanidides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
05/11/2006WO2006050496A1 Substituted anthracenes and electronic devices containing the substituted anthracenes
05/11/2006WO2006049891A1 Trisubstituted thiophenes as progesterone receptor modulators
05/11/2006US20060100456 Diastereoselective method of preparing olefins by means of the horner-wadsworthemmons reaction, comprising the addition of a tris-(polyoxaalkyl)-amine sequestering agent
05/11/2006US20060100261 Furan or thiopene derivative and medicinal use thereof
05/11/2006US20060100252 Beta 3 adrenergic receptor agonists; pollakiuria or urinary incontinence; antiulcer, overactive bladder, pancreatitis, obesity, diabetes, insulin resistance, hypertriglyceridemia, hypercholesterolemia, tocolytic agents; 4'-[2-(2-hydroxy-2-phenylethyl]amino]ethyl]-4-biphenylyl]acetic acid
05/11/2006US20060100250 Biphenyl derivatives and their use as fungicides
05/11/2006CA2585337A1 Trisubstituted thiophenes as progesterone receptor modulators
05/10/2006EP1655990A1 Wireless microphone communication system
05/10/2006EP1654248A1 Acene-thiophene semiconductors
05/10/2006EP1654247A1 Alkynyl aryl carboxamides
05/10/2006EP1654219A2 Hydrazide derivatives as prostaglandin receptors modulators